Laboratory medicine
23andMe, Inc.
23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is cataloged as an AI-enabled laboratory medicine product associated with immunology workflows. Source records identify 23andMe, Inc. as the associated developer or manufacturer.
Designed for
Laboratory professional and clinician
Care setting
Clinical laboratory and diagnostic workflows
Specialty
Immunology
Catalog status
This catalog entry is based on 1 public source record. RIR has not yet characterized the product's clinical evidence.
This is a catalog and scoping record. RIR has not completed a public-evidence assessment of this product. Inclusion is not endorsement, verification, certification, or a recommendation.
What the source record supports
The linked sources support catalog inclusion and identify the product and associated organization. They do not constitute an RIR evidence assessment.
What still needs verification
Current product-family mapping, exact intended use and version, present availability, independent performance, subgroup behavior, workflow effects, safety monitoring, and patient outcomes may remain unresolved.
Product facts
Sources represented
1 source records used to identify or scope this catalog entry.
Current source base
This catalog entry is based on 1 public source record. RIR has not yet characterized the product's clinical evidence.
Important limitation
Current product-family mapping, exact intended use and version, present availability, independent performance, subgroup behavior, workflow effects, safety monitoring, and patient outcomes may remain unresolved.
Questions to ask